HENRY SCHEIN INC HSIC

Industrials SIC 5047 - Wholesale-Medical, Dental & Hospital Equipment & Supplies NAICS Wholesale Trade › Merchant Wholesalers, Durable Goods › Professional and Commercial Equipment and Supplies Merchant Wholesalers › Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers derived Nasdaq

technology.

based dental and medical practitioners, as well as alternate sites of care.

practitioner can provide better clinical care.

With 94 years of experience distributing health care products, we have built a vast base of small, mid-sized

Last close 84.96 2026-10-23
Market cap $9.47B 2026-06-27 share count
52-week range 62.15 - 92.18

Valuation FY2025 figures against the last close

P/S0.7x
P/E26.0x
P/FCF16.5x
EV/EBITDA10.5x
Dividend yield—
Diluted EPS3.27

Where the revenue comes from as reported in the latest 10-K

Revenue by geography

  • United States
  • Other
Revenue by geography, 2 categories over 3 years. The same figures are in the table below. FY2025 United States, FY2025: 9.1B (69.0%) 69% United States Other, FY2025: 4.1B (31.0%) 31% Other FY2024 United States, FY2024: 8.8B (69.6%) 70% Other, FY2024: 3.8B (30.4%) 30% FY2023 United States, FY2023: 8.7B (70.2%) 70% Other, FY2023: 3.7B (29.8%) 30%
Region FY2025FY2024FY2023
United States $9.10B $8.82B $8.66B
Other $4.09B $3.85B $3.68B

As the company reported it, from the “Segment and Geographic Data (Operations by Geographic Area) (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.

Revenue by segment

  • Global Distribution and Value-Added Services
  • Global Specialty Products
  • Global Technology
Revenue by segment, 3 categories over 3 years. The same figures are in the table below. FY2025 Global Distribution and Value-Added Services, FY2025: 11.1B (84.3%) 84% Global Distribution and Value-Added Services Global Specialty Products, FY2025: 1.4B (10.5%) 11% Global Technology, FY2025: 675M (5.1%) 5% FY2024 Global Distribution and Value-Added Services, FY2024: 10.7B (84.7%) 85% Global Specialty Products, FY2024: 1.3B (10.4%) 10% Global Technology, FY2024: 630M (5.0%) 5% FY2023 Global Distribution and Value-Added Services, FY2023: 10.5B (85.3%) 85% Global Specialty Products, FY2023: 1.2B (9.8%) 10% Global Technology, FY2023: 602M (4.9%) 5%
Segment FY2025FY2024FY2023
Global Distribution and Value-Added Services $11.12B $10.73B $10.53B
Global Specialty Products $1.39B $1.31B $1.21B
Global Technology $675.0M $630.0M $602.0M

As the company reported it, from the “Segment and Geographic Data (Business Segment Information) (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Segments are the filer's own reporting structure, which is a decision about how it runs itself rather than a standard taxonomy: two companies in the same industry routinely divide themselves along different lines, so these are worth reading down a single company rather than across two. Slices under 1% are folded into “Other”.

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $13.18B$12.67B$12.34B$12.65B$12.40B$10.12B$9.99B$9.42B$8.88B$11.57B
Cost of revenue $9.08B$8.66B$8.48B$8.82B$8.73B$7.30B$6.89B$6.51B$6.14B$8.35B
Gross profit $4.11B$4.02B$3.86B$3.83B$3.67B$2.82B$3.09B$2.91B$2.75B$3.23B
SG&A $3.08B$3.03B$2.96B$2.77B$2.63B$2.09B$2.36B$2.22B$2.07B$2.41B
Total operating expenses ———————$2.70B$2.53B$2.41B
Operating income $653.0M$621.0M$615.0M$747.0M$852.0M$535.0M$718.3M$600.6M$669.8M$771.6M
Interest expense $150.0M$131.0M$87.0M$35.0M$27.0M$41.0M$50.8M$76.0M$51.1M$31.9M
Pre-tax income $533.0M$513.0M$542.0M$721.0M$831.0M$500.0M$680.3M$536.8M$629.8M$755.8M
Income tax $126.0M$128.0M$120.0M$170.0M$198.0M$95.0M$159.5M$107.4M$309.0M$218.0M
Net income $419.0M$398.0M$436.0M$566.0M$660.0M$404.0M$694.7M$535.9M$406.3M$506.8M
EPS, basic 3.293.073.183.954.512.834.703.512.593.14
EPS, diluted 3.273.053.163.914.452.824.653.492.573.10
Shares, diluted (wtd. avg.) 121.7M127.8M131.7M137.8M141.8M143.4M149.3M153.7M158.2M163.7M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $156.0M$122.0M$171.0M$117.0M$118.0M$421.0M$106.1M$56.9M$158.0M$42.7M
Receivables $1.65B$1.48B$1.86B$1.44B$1.45B$1.42B$1.25B$1.17B$1.52B$1.25B
Inventory $2.00B$1.81B$1.81B$1.96B$1.86B$1.51B$1.43B$1.42B$1.93B$1.67B
Total current assets $4.46B$3.98B$4.49B$3.99B$3.84B$3.79B$3.23B$4.18B$4.09B$3.34B
Property, plant and equipment ————$366.5M$342.0M$329.6M$314.2M$375.0M$333.9M
Goodwill $4.21B$3.89B$3.88B$2.89B$2.85B$2.50B$2.46B$2.08B$1.55B$2.02B
Other intangibles $1.02B$1.02B$916.0M$587.0M$668.0M$479.4M$572.9M$376.0M$669.6M$621.2M
Total assets $11.21B$10.22B$10.57B$8.61B$8.48B$7.77B$7.15B$8.50B$7.86B$6.81B
Accounts payable $1.15B$962.0M$1.02B$1.00B$1.05B$1.01B$880.3M$785.8M$1.15B$1.01B
Short-term debt $764.0M$650.0M$264.0M$103.0M$51.0M$73.4M$24.0M$951.5M——
Total current liabilities $3.23B$2.80B$2.68B$2.22B$2.31B$2.28B$2.04B$3.22B$2.83B$2.32B
Long-term debt ———$1.05B$822.0M—————
Total liabilities $6.42B$5.38B$5.42B$3.94B$3.81B$3.46B$3.23B$4.65B$4.21B$3.35B
Retained earnings $3.29B$3.77B$3.86B$3.68B$3.60B$3.45B$3.12B$3.21B$2.94B$2.98B
Total equity $3.25B$3.39B$4.29B$4.09B$4.06B$3.98B$3.63B$3.54B$2.82B$2.80B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $712.0M$848.0M$500.0M$602.0M$710.0M$599.0M$654.1M$684.7M$545.5M$642.6M
Depreciation and amortisation $311.0M$297.0M$248.0M$212.0M$210.0M$186.0M$184.9M$143.6M$133.9M$169.8M
Stock-based compensation $39.0M$39.0M$39.0M$54.0M$78.0M$9.0M$44.9M$32.6M$36.8M$58.2M
Capital expenditure $139.0M$148.0M$147.0M$96.0M$79.0M$49.0M$76.2M$71.3M$62.4M$70.2M
Investing cash flow -$400.0M-$430.0M-$1.14B-$276.0M-$677.0M-$115.0M-$424.4M-$193.0M-$342.3M-$316.4M
Financing cash flow -$188.0M-$510.0M$701.0M-$315.0M-$333.0M-$187.0M-$216.0M-$603.8M-$112.6M-$327.3M
Buybacks $850.0M$385.0M$250.0M$485.0M$401.0M$74.0M$525.0M$200.0M$450.0M$550.0M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-146317.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 5B 10B 15B Revenue, FY2016: 11.6B Gross profit, FY2016: 3.2B Net income, FY2016: 506.8M Revenue, FY2017: 8.9B Gross profit, FY2017: 2.7B Net income, FY2017: 406.3M Revenue, FY2018: 9.4B Gross profit, FY2018: 2.9B Net income, FY2018: 535.9M Revenue, FY2019: 10B Gross profit, FY2019: 3.1B Net income, FY2019: 694.7M Revenue, FY2020: 10.1B Gross profit, FY2020: 2.8B Net income, FY2020: 404M Revenue, FY2021: 12.4B Gross profit, FY2021: 3.7B Net income, FY2021: 660M Revenue, FY2022: 12.6B Gross profit, FY2022: 3.8B Net income, FY2022: 566M Revenue, FY2023: 12.3B Gross profit, FY2023: 3.9B Net income, FY2023: 436M Revenue, FY2024: 12.7B Gross profit, FY2024: 4B Net income, FY2024: 398M Revenue, FY2025: 13.2B Gross profit, FY2025: 4.1B Net income, FY2025: 419M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $11.57B $8.88B $9.42B $9.99B $10.12B $12.40B $12.65B $12.34B $12.67B $13.18B
Gross profit $3.23B $2.75B $2.91B $3.09B $2.82B $3.67B $3.83B $3.86B $4.02B $4.11B
Net income $506.8M $406.3M $535.9M $694.7M $404.0M $660.0M $566.0M $436.0M $398.0M $419.0M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Regulation FD disclosure Item 7.01
  • Results announced Item 2.02
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Officer or director change Item 5.02
  • Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 5047

TickerCompanyMarket capP/ERevenue growth
ACH ACCENDRA HEALTH INC/VA/ $16.7M — 3.1%